PhoenixBio Co., Ltd. (6190) Financial Statements

0 Followers

PhoenixBio Co., Ltd. Financial Overview

PhoenixBio Co., Ltd.'s market cap is currently ¥1.47B. The company's EPS TTM is ¥-112.33; its P/E ratio is 12.06; PhoenixBio Co., Ltd. is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	¥ 1.57B	¥ 1.54B	¥ 1.72B	¥ 2.12B	¥ 1.32B
Gross Profit	¥ 1.19B	¥ 1.11B	¥ 1.20B	¥ 1.56B	¥ 727.79M
Operating Income	¥ 82.77M	¥ -135.17M	¥ 11.06M	¥ 508.45M	¥ -167.62M
EBITDA	¥ 116.52M	¥ -396.12M	¥ 87.94M	¥ 537.42M	¥ -305.81M
Net Income	¥ 125.23M	¥ -445.65M	¥ 26.38M	¥ 493.33M	¥ -387.97M
Balance Sheet
Cash & Short-Term Investments	¥ 1.15B	¥ 1.15B	¥ 1.39B	¥ 1.56B	¥ 1.33B
Total Assets	¥ 2.19B	¥ 2.31B	¥ 2.74B	¥ 3.02B	¥ 2.28B
Total Debt	¥ 486.64M	¥ 565.36M	¥ 723.93M	¥ 1.13B	¥ 1.04B
Net Debt	¥ -660.53M	¥ -584.03M	¥ -660.96M	¥ -425.35M	¥ -286.59M
Total Liabilities	¥ 640.05M	¥ 944.82M	¥ 946.58M	¥ 1.50B	¥ 1.45B
Stockholders' Equity	¥ 1.55B	¥ 1.37B	¥ 1.80B	¥ 1.51B	¥ 828.15M
Cash Flow
Free Cash Flow	¥ 56.42M	¥ -94.24M	¥ -118.08M	¥ 265.12M	¥ 9.63M
Operating Cash Flow	¥ 68.86M	¥ -73.00M	¥ -79.31M	¥ 277.49M	¥ 16.40M
Investing Cash Flow	¥ -13.75M	¥ -27.98M	¥ 115.36M	¥ -156.34M	¥ -6.97M
Financing Cash Flow	¥ -88.01M	¥ -128.00M	¥ -244.88M	¥ 86.63M	¥ -34.66M

Currency in JPY

PhoenixBio Co., Ltd. Earnings and Revenue History

Income Statement >

PhoenixBio Co., Ltd. Debt to Assets

Balance Sheet >

PhoenixBio Co., Ltd. Cash Flow

Cash Flow >

PhoenixBio Co., Ltd. Forecast EPS vs Actual EPS

Earnings >